Expression patterns of CD44 and AREG under treatment with selective Tyrosine Kinase inhibitors in HPV+ and HPV− squamous cell carcinoma
Background: We investigated the expression patterns of cluster of differentiation (CD) 44 and amphiregulin (AREG), two signaling molecules essential for cell proliferation and differentiation, under the influence of selective tyrosine kinase inhibitors (TKIs) in human papillomavirus (HPV)+ and HPV−...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
September-October 2020
|
| In: |
Cancer genomics & proteomics
Year: 2020, Jahrgang: 17, Heft: 5, Pages: 579-585 |
| ISSN: | 1790-6245 |
| DOI: | 10.21873/cgp.20214 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.21873/cgp.20214 Verlag, kostenfrei, Volltext: https://cgp.iiarjournals.org/content/17/5/579 
|
| Verfasserangaben: | Benjamin Kansy, Christoph Aderhold, Lena Huber, Sonja Ludwig, Richard Birk, Anne Lammert, Stephan Lang, Nicole Rotter and Benedikt Kramer |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 194843489X | ||
| 003 | DE-627 | ||
| 005 | 20260112102106.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260112s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21873/cgp.20214 |2 doi | |
| 035 | |a (DE-627)194843489X | ||
| 035 | |a (DE-599)KXP194843489X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kansy, Benjamin Alexander |d 1985- |e VerfasserIn |0 (DE-588)1078338760 |0 (DE-627)838351115 |0 (DE-576)45072560X |4 aut | |
| 245 | 1 | 0 | |a Expression patterns of CD44 and AREG under treatment with selective Tyrosine Kinase inhibitors in HPV+ and HPV− squamous cell carcinoma |c Benjamin Kansy, Christoph Aderhold, Lena Huber, Sonja Ludwig, Richard Birk, Anne Lammert, Stephan Lang, Nicole Rotter and Benedikt Kramer |
| 246 | 3 | 0 | |a Im Titel ist das Plus- und Minuszeichen bei "HPV" hochgestellt |
| 246 | 3 | 3 | |a Expression patterns of CD forty-four and AREG under treatment with selective Tyrosine Kinase inhibitors in HPV plus and HPV minus squamous cell carcinoma |
| 264 | 1 | |c September-October 2020 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 12.01.2026 | ||
| 520 | |a Background: We investigated the expression patterns of cluster of differentiation (CD) 44 and amphiregulin (AREG), two signaling molecules essential for cell proliferation and differentiation, under the influence of selective tyrosine kinase inhibitors (TKIs) in human papillomavirus (HPV)+ and HPV− squamous carcinoma cell lines. Materials and Methods: The protein expression of CD44 and AREG was determined by sandwich enzyme-linked immunosorbent assay in HPV− cell lines UMSCC-11A and UMSCC-14C, and HPV+ CERV-196 cells after TKI treatment. Results: The expression of AREG and CD44 was dependent on the cell line's HPV status. AREG expression increased after incubation with nilotinib in HPV+ tumor cells. The expression of CD44 was significantly influenced by all drugs; its expression under selective epidermal growth factor receptor inhibition was mostly reduced, whereas nilotinib led to an exceptional increase of CD44 expression. Conclusion: The selective drug treatment options significantly influenced the expression of CD44 and AREG in HPV− and HPV+ tumor cells, constituting the need for personalized treatment options. | ||
| 650 | 4 | |a afatinib | |
| 650 | 4 | |a AREG | |
| 650 | 4 | |a CD44 | |
| 650 | 4 | |a dasatinib | |
| 650 | 4 | |a drug resistance | |
| 650 | 4 | |a erlotinib | |
| 650 | 4 | |a gefitinib | |
| 650 | 4 | |a head and neck squamous cell carcinoma | |
| 650 | 4 | |a nilotinib | |
| 700 | 1 | |a Aderhold, Marc Christoph |d 1984- |e VerfasserIn |0 (DE-588)1015507301 |0 (DE-627)66910700X |0 (DE-576)350716404 |4 aut | |
| 700 | 1 | |a Huber, Lena |d 1989- |e VerfasserIn |0 (DE-588)1209606402 |0 (DE-627)1697276873 |4 aut | |
| 700 | 1 | |a Ludwig, Sonja |d 1987- |e VerfasserIn |0 (DE-588)120924277X |0 (DE-627)1696857562 |4 aut | |
| 700 | 1 | |a Birk, Richard |d 1984- |e VerfasserIn |0 (DE-588)1033785636 |0 (DE-627)742508803 |0 (DE-576)381448746 |4 aut | |
| 700 | 1 | |a Lammert, Anne |d 1983- |e VerfasserIn |0 (DE-588)137533365 |0 (DE-627)695845284 |0 (DE-576)303406097 |4 aut | |
| 700 | 1 | |a Lang, Stephan |d 1966- |e VerfasserIn |0 (DE-588)1163226122 |0 (DE-627)1027443206 |0 (DE-576)507835808 |4 aut | |
| 700 | 1 | |a Rotter, Nicole |d 1970- |e VerfasserIn |0 (DE-588)118085638 |0 (DE-627)079235514 |0 (DE-576)178653888 |4 aut | |
| 700 | 1 | |a Kramer, Benedikt |d 1985- |e VerfasserIn |0 (DE-588)1067455698 |0 (DE-627)818750677 |0 (DE-576)42666048X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancer genomics & proteomics |d Kapandriti : Inst., 2004 |g 17(2020), 5 vom: Sept./Okt., Seite 579-585 |h Online-Ressource |w (DE-627)387482733 |w (DE-600)2145919-8 |w (DE-576)372066348 |x 1790-6245 |7 nnas |a Expression patterns of CD44 and AREG under treatment with selective Tyrosine Kinase inhibitors in HPV+ and HPV− squamous cell carcinoma |
| 773 | 1 | 8 | |g volume:17 |g year:2020 |g number:5 |g month:09/10 |g pages:579-585 |g extent:7 |a Expression patterns of CD44 and AREG under treatment with selective Tyrosine Kinase inhibitors in HPV+ and HPV− squamous cell carcinoma |
| 856 | 4 | 0 | |u https://doi.org/10.21873/cgp.20214 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |7 0 |
| 856 | 4 | 0 | |u https://cgp.iiarjournals.org/content/17/5/579 |x Verlag |z kostenfrei |3 Volltext |7 0 |
| 951 | |a AR | ||
| 992 | |a 20260112 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 1067455698 |a Kramer, Benedikt |m 1067455698:Kramer, Benedikt |d 60000 |d 62100 |e 60000PK1067455698 |e 62100PK1067455698 |k 0/60000/ |k 1/60000/62100/ |p 9 |y j | ||
| 998 | |g 118085638 |a Rotter, Nicole |m 118085638:Rotter, Nicole |d 60000 |d 62100 |e 60000PR118085638 |e 62100PR118085638 |k 0/60000/ |k 1/60000/62100/ |p 8 | ||
| 998 | |g 137533365 |a Lammert, Anne |m 137533365:Lammert, Anne |d 60000 |d 62100 |e 60000PL137533365 |e 62100PL137533365 |k 0/60000/ |k 1/60000/62100/ |p 6 | ||
| 998 | |g 1033785636 |a Birk, Richard |m 1033785636:Birk, Richard |d 60000 |d 62100 |e 60000PB1033785636 |e 62100PB1033785636 |k 0/60000/ |k 1/60000/62100/ |p 5 | ||
| 998 | |g 120924277X |a Ludwig, Sonja |m 120924277X:Ludwig, Sonja |d 60000 |e 60000PL120924277X |k 0/60000/ |p 4 | ||
| 998 | |g 1209606402 |a Huber, Lena |m 1209606402:Huber, Lena |d 60000 |e 60000PH1209606402 |k 0/60000/ |p 3 | ||
| 998 | |g 1015507301 |a Aderhold, Marc Christoph |m 1015507301:Aderhold, Marc Christoph |d 60000 |d 62100 |e 60000PA1015507301 |e 62100PA1015507301 |k 0/60000/ |k 1/60000/62100/ |p 2 | ||
| 999 | |a KXP-PPN194843489X |e 4844881094 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Benjamin Kansy, Christoph Aderhold, Lena Huber, Sonja Ludwig, Richard Birk, Anne Lammert, Stephan Lang, Nicole Rotter and Benedikt Kramer"]},"origin":[{"dateIssuedDisp":"September-October 2020","dateIssuedKey":"2020"}],"id":{"eki":["194843489X"],"doi":["10.21873/cgp.20214"]},"recId":"194843489X","type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"given":"Benjamin Alexander","role":"aut","family":"Kansy","display":"Kansy, Benjamin Alexander"},{"given":"Marc Christoph","family":"Aderhold","role":"aut","display":"Aderhold, Marc Christoph"},{"family":"Huber","role":"aut","display":"Huber, Lena","given":"Lena"},{"given":"Sonja","display":"Ludwig, Sonja","role":"aut","family":"Ludwig"},{"role":"aut","family":"Birk","display":"Birk, Richard","given":"Richard"},{"display":"Lammert, Anne","family":"Lammert","role":"aut","given":"Anne"},{"given":"Stephan","display":"Lang, Stephan","role":"aut","family":"Lang"},{"role":"aut","family":"Rotter","display":"Rotter, Nicole","given":"Nicole"},{"display":"Kramer, Benedikt","role":"aut","family":"Kramer","given":"Benedikt"}],"note":["Gesehen am 12.01.2026"],"titleAlt":[{"title":"Expression patterns of CD forty-four and AREG under treatment with selective Tyrosine Kinase inhibitors in HPV plus and HPV minus squamous cell carcinoma"}],"language":["eng"],"physDesc":[{"extent":"7 S."}],"title":[{"title":"Expression patterns of CD44 and AREG under treatment with selective Tyrosine Kinase inhibitors in HPV+ and HPV− squamous cell carcinoma","title_sort":"Expression patterns of CD44 and AREG under treatment with selective Tyrosine Kinase inhibitors in HPV+ and HPV− squamous cell carcinoma"}],"relHost":[{"language":["eng"],"pubHistory":["1.2004 -"],"note":["Gesehen am 27.05.2020"],"name":{"displayForm":["publ. by the International Institute of Anticancer Research"]},"origin":[{"publisher":"Inst.","publisherPlace":"Kapandriti","dateIssuedKey":"2004","dateIssuedDisp":"2004-"}],"disp":"Expression patterns of CD44 and AREG under treatment with selective Tyrosine Kinase inhibitors in HPV+ and HPV− squamous cell carcinomaCancer genomics & proteomics","type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"issn":["1790-6245"],"zdb":["2145919-8"],"eki":["387482733"]},"recId":"387482733","title":[{"title":"Cancer genomics & proteomics","title_sort":"Cancer genomics & proteomics"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"extent":"7","issue":"5","year":"2020","pages":"579-585","volume":"17","text":"17(2020), 5 vom: Sept./Okt., Seite 579-585"}}]} | ||
| SRT | |a KANSYBENJAEXPRESSION2020 | ||